Comparison of efficacy and safety of salvage-line nivolumab monotherapy between 240 and 480 mg for advanced esophageal squamous cell carcinoma.

被引：0
|
作者：
Murashima, Yuko
Yamamoto, Shun
Hirose, Toshiharu
Kadono, Toru
Ikeda, Go
Ohara, Akihiro
Itoyama, Mai
Yokoyama, Kazuki
Honma, Yoshitaka
Ishiyama, Koshiro
Oguma, Junya
Daiko, Hiroyuki
Kato, Ken
机构：
[1] Natl Canc Ctr, Dept Head & Neck, Esophageal Med Oncol, Tokyo, Japan
[2] Natl Canc Ctr, Dept Esophageal Surg, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
317
引用
下载
收藏
页码：317 / 317
页数：1
相关论文
共 50 条
  • [1] Efficacy and Safety of Salvage-line Nivolumab Monotherapy for Advanced Esophageal Squamous Cell Carcinoma: Comparison of 240 mg Versus 480 mg Doses
    Murashima, Yuko
    Yamamoto, Shun
    Hirose, Toshiharu
    Kadono, Toru
    Ikeda, Go
    Ohara, Akihiro
    Itoyama, Mai
    Yokoyama, Kazuki
    Honma, Yoshitaka
    Ishiyama, Koshiro
    Oguma, Jyunya
    Daiko, Hiroyuki
    Kato, Ken
    JOURNAL OF GASTROINTESTINAL CANCER, 2024, 55 (03) : 1345 - 1351
  • [2] Retrospective study of nivolumab monotherapy for advanced esophageal squamous cell carcinoma.
    Mikuni, Hayato
    Yamamoto, Shun
    Oshima, Kotoe
    Hirano, Hidekazu
    Okita, Natsuko
    Shoji, Hirokazu
    Honma, Yoshitaka
    Iwasa, Satoru
    Takashima, Atsuo
    Boku, Narikazu
    Kato, Ken
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [3] Safety and efficacy of nivolumab therapy in patients with advanced esophageal squamous cell carcinoma
    Shimada, Seitaro
    Tsushima, Takahiro
    Shirasu, Hiromichi
    Kawakami, Takeshi
    Hamauchi, Satoshi
    Todaka, Akiko
    Yokota, Tomoya
    Yamazaki, Kentaro
    Fukutomi, Akira
    Onozawa, Yusuke
    Yasui, Hirofumi
    ANNALS OF ONCOLOGY, 2021, 32 : S328 - S328
  • [4] The overall safety and short-term efficacy of nivolumab plus ipilimumab for advanced esophageal squamous cell carcinoma.
    Shiraishi, Kazuhiro
    Yamamoto, Shun
    Yoshinami, Yuri
    Ohara, Akihiro
    Itoyama, Mai
    Yokoyama, Kazuki
    Honma, Yoshitaka
    Kashiraha, Tairo
    Kurita, Daisuke
    Ishiyama, Koshiro
    Oguma, Junya
    Igaki, Hiroshi
    Daiko, Hiroyuki
    Kato, Ken
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 329 - 329
  • [5] Retrospective study of nivolumab monotherapy for advanced esophageal squamous cell carcinoma
    Mikuni, Hayato
    Yamamoto, Shun
    Oshima, Kotoe
    Hirano, Hidekazu
    Okita, Natsuko
    Shoji, Hirokazu
    Honma, Yoshitaka
    Iwasa, Satoru
    Takashima, Atsuo
    Boku, Narikazu
    Kato, Ken
    ANNALS OF ONCOLOGY, 2021, 32 : S298 - S298
  • [6] Safety and efficacy of conversion therapy for esophageal squamous cell carcinoma.
    Tsuji, Takayuki
    Kawakubo, Hirofumi
    Takeuchi, Masashi
    Matsuda, Satoru
    Fukuda, Kazumasa
    Nakamura, Rieko
    Kitagawa, Yuko
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 362 - 362
  • [7] Safety and short-term efficacy of adjuvant nivolumab after neoadjuvant docetaxel, cisplatin, and fluorouracil for locally advanced esophageal squamous cell carcinoma.
    Okunaka, Mashiro
    Kotani, Daisuke
    Sato, Kazuma
    Fujiwara, Naoto
    Mishima, Saori
    Shitara, Kohei
    Fujita, Takeo
    Kojima, Takashi
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 271 - 271
  • [8] The efficacy and safety of toripalimab combined with definitive chemoradiotherapy for patients with locally advanced esophageal squamous cell carcinoma.
    Xi, Mian
    Zhu, Yujia
    Li, Qiao-Qiao
    Zhao, Lei
    Yang, Yadi
    Hu, Yonghong
    Liu, Mengzhong
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [9] Efficacy and safety of endostar in the treatment of advanced lung squamous cell carcinoma.
    Hu, Weiheng
    Fang, Jian
    Nie, Jun
    Dai, Ling
    Zhang, Jie
    Chen, Xiaoling
    Ma, Xiangjuan
    Tan, Guangming
    Wu, Di
    Han, Jindi
    Han, Sen
    Wang, Yang
    Long, Jieran
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [10] Efficacy and safety of apatinib with or without radiotherapy as second-line or beyond therapy in patients with advanced/recurrent esophageal squamous cell carcinoma.
    Lv, Jiahua
    Li, Tao
    Wang, Qifeng
    Fan, Yu
    Wang, Junchao
    Lang, Jinyi
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345